Current Drug Targets
Title:Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation)
Volume: 13 Issue: 9
Author(s): Hiroaki Miyajima
Affiliation:
Export Options
About this article
Cite this article as:
Miyajima Hiroaki, Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation), Current Drug Targets 2012; 13 (9) . https://dx.doi.org/10.2174/138945012802002339
DOI https://dx.doi.org/10.2174/138945012802002339 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pantothenate Kinase-Associated Neurodegeneration
Current Drug Targets A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Systemic Redox Biomarkers in Neurodegenerative Diseases
Current Drug Metabolism Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Current Neuropharmacology The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Current Metabolomics Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders
Current Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism Antimalarial Drugs and their Useful Therapeutic Lives: Rational Drug Design Lessons from Pleiotropic Action of Quinolines and Artemisinins
Current Drug Discovery Technologies The Effects of Vitamin B in Depression
Current Medicinal Chemistry Role of Vitamins in Neurodegenerative Diseases: A Review
CNS & Neurological Disorders - Drug Targets Aceruloplasminemia
Current Drug Targets Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease
Current Alzheimer Research Vitamins and Cognition: A Nutrigenomics Perspective
Current Nutrition & Food Science Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Current Neuropharmacology Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Neuroferritinopathy: Update on Clinical Features and Pathogenesis
Current Drug Targets Influence of Vanin-1 and Catalytic Products in Liver During Normal and Oxidative Stress Conditions
Current Medicinal Chemistry